DEERFIELD, IL – January 5, 2015 – Sterigenics International LLC Chief Executive Officer Michael Mulhern will present a company update at the 33rd Annual J.P. Morgan Healthcare Conference in San Francisco on Tuesday, January 13, 2015 at 2:30 pm PT. Sterigenics is a leading global provider of contract sterilization, gamma technologies and medical isotopes, and a portfolio company of GTCR.
Key 2014 Sterigenics’ developments include:
- Acquisition of Nordion Inc., the world’s largest provider of Cobalt-60 used in the gamma sterilization process, creating the only vertically integrated sterilization company in the world;
- Acquisition of Gammarad, Italy’s leading gamma irradiation sterilization company, providing over 4 million cubic feet of processing capability and a second Sterigenics Gamma irradiation site in Western Europe;
- Acquisition of Food Technology Service, Inc., a Gamma irradiation operation in Mulberry, Florida;
- Investing $32 million in growth capital to expand existing facilities across the Americas and Europe.
Sterigenics International LLC is a global leader in outsourced contract sterilization services, gamma technologies and medical isotopes, and the only vertically integrated sterilization company in the world. Operating out of 43 facilities in 12 countries across the Americas, Europe and Asia, Sterigenics provides contract sterilization and ionization services for the medical device, pharmaceutical, food safety, and high performance/specialty materials industries. Through SteriPro® Labs service, Sterigenics offers microbiological and analytical testing and consultancy to assist customers in developing and maintaining sterilization solutions in medical devices, tissue/implantable products, and pharmaceuticals and biologics fields. Subsidiary Nordion Inc. positions Sterigenics as the world’s largest provider of Cobalt-60 used in the gamma sterilization process as well as medical isotopes used in the diagnosis and treatment of various diseases and cancers. Sterigenics International LLC serves more than 2500 customers around the world.
Founded in 1980, GTCR is a leading private equity firm focused on investing in growth companies in the Financial Services & Technology, Healthcare and Information Services & Technology industries. The Chicago-based firm pioneered The Leaders Strategy™ – finding and partnering with management leaders in core domains to identify, acquire and build market-leading companies through transformational acquisitions and organic growth. Since its inception, GTCR has invested more than $10 billion in over 200 companies. For more information, please visit www.gtcr.com.
FOR MORE INFORMATION CONTACT:
John Steven Vita Communications